Skip to main content
. 2017 Jul 6;15:125. doi: 10.1186/s12957-017-1192-6

Table 1.

Clinicopathological characteristics of patients

Variable RERBT (n = 40) C-TURBT (n = 50) P value
Age (year) 60.65 ± 13.08 60.80 ± 14.04 0.959
Size 0.650
≤3 cm (n) 32 (80%) 38 (76%)
>3 cm (n) 8 (20%) 12 (24%)
Gender 0.166
Male 35 (87.5%) 38 (76%)
Female 5 (12.5%) 12 (24%)
Tumor multiplicity 0.705
Single 29 (72.5%) 38 (76%)
Multiple 11 (27.5%) 12 (24%)
Tumor morphology 0.686
Pedunculate 28 (70%) 33 (66%)
Flat 12 (30%) 17 (34%)
Stage 0.119
Ta 15 (37.5%) 27 (54%)
T1 25 (62.5%) 23 (46%)
Grade (WHO2004) 0.250
LMP 9 (22.5%) 12 (24%)
LG 22 (55%) 23 (46%)
HG 9 (22.5%) 15 (30%)
Location 0.753
Lateral wall 22 (55%) 22 (44%)
Posterior wall 5 (12.5%) 8 (16%)
Anterior wall 6 (15%) 7 (14%)
Dome 0 (0) 3 (6%)
Trigone/bladder neck 4 (10%) 4 (8%)
Multiple 3 (7.5%) 6 (12%)

RERBT retrograde en bloc resection of bladder tumor, C-TURBT conventional transurethral resection of bladder tumor, LMP papillary urothelial neoplasia of low malignant potential, LG low-grade papillary urothelial carcinoma, HG high-grade papillary urothelial carcinoma